| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1160/TH07-08-0481 |
| P698 | PubMed publication ID | 18278179 |
| P50 | author | Lina Badimon | Q38545654 |
| Cristina Rodríguez | Q47504226 | ||
| José Martínez-González | Q47504227 | ||
| Olivier Calvayrac | Q80710172 | ||
| P2093 | author name string | Maurizio Gentile | |
| Lluis Martorell | |||
| P433 | issue | 2 | |
| P304 | page(s) | 305-315 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Thrombosis and Haemostasis | Q15724413 |
| P1476 | title | Thrombin and protease-activated receptors (PARs) in atherothrombosis | |
| P478 | volume | 99 |
| Q41839457 | A critical role for chloride channel-3 (CIC-3) in smooth muscle cell activation and neointima formation |
| Q34003829 | Activation of swelling-activated chloride current by tumor necrosis factor-alpha requires ClC-3-dependent endosomal reactive oxygen production |
| Q26801144 | Adjunctive therapies to reduce thrombotic events in patients with a history of myocardial infarction: role of vorapaxar |
| Q33960909 | An integrated mathematical model of thrombin-, histamine-and VEGF-mediated signalling in endothelial permeability |
| Q38964211 | Anti-thrombotic and pro-fibrinolytic effects of levosimendan in human endothelial cells in vitro. |
| Q37929838 | Antiplatelet therapy: thrombin receptor antagonists |
| Q37202070 | Association between Stable Coronary Artery Disease and In Vivo Thrombin Generation |
| Q49593658 | Association of FV G1691A Polymorphism but not A4070G With Coronary Artery Disease. |
| Q39379451 | Characterization of the thrombin generation potential of leukemic and solid tumor cells by calibrated automated thrombography |
| Q90452318 | Coagulation, Microenvironment and Liver Fibrosis |
| Q35778357 | Competition-cooperation relationship networks characterize the competition and cooperation between proteins |
| Q38966854 | Contraction of endothelial cells: 40 years of research, but the debate still lives |
| Q60923989 | Coronary Atherothrombotic Disease: Progress in Antiplatelet Therapy |
| Q28068706 | Direct Thrombin Inhibitors Prevent Left Atrial Remodeling Associated With Heart Failure in Rats |
| Q33520217 | Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control |
| Q30432112 | Entamoeba histolytica Infection and Secreted Proteins Proteolytically Damage Enteric Neurons |
| Q30422672 | Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model. |
| Q51740874 | Exploring the Phe-Gly dipeptide-derived piperazinone scaffold in the search for antagonists of the thrombin receptor PAR1. |
| Q37950860 | Fibrinogen as a key regulator of inflammation in disease |
| Q38526491 | G-protein-mediated signaling in vascular smooth muscle cells - implications for vascular disease |
| Q90250080 | Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta-Analysis |
| Q34787891 | MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells |
| Q38586884 | MEMBRANE TYPE 1-MATRIX METALLOPROTEINASE (MT1-MMP) IDENTIFIED AS A MULTIFUNCTIONAL REGULATOR OF VASCULAR RESPONSES. |
| Q28081366 | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) |
| Q37312105 | Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration |
| Q34251521 | Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors |
| Q28586998 | Platelet biogenesis and functions require correct protein O-glycosylation |
| Q37327359 | Platelet-mediated angiogenesis is independent of VEGF and fully inhibited by aspirin |
| Q89868219 | Preliminary Observations on the Antihypertension Action of Dabigatran Etexilate in Patients With Nonvalvular Atrial Fibrillation: A Prospective Multicenter Single-Arm Interventional Study |
| Q35166026 | Properties of procoagulant platelets: defining and characterizing the subpopulation binding a functional prothrombinase |
| Q88732568 | Protease-activated receptor 1 inhibits cholesterol efflux and promotes atherogenesis via cullin 3-mediated degradation of the ABCA1 transporter |
| Q91788809 | Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors |
| Q38393381 | Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells. |
| Q34168176 | RNA-seq reveals novel transcriptome of genes and their isoforms in human pulmonary microvascular endothelial cells treated with thrombin |
| Q40831873 | Store-independent Orai1/3 channels activated by intracrine leukotriene C4: role in neointimal hyperplasia |
| Q35591080 | Targeting blood thrombogenicity precipitates atherothrombotic events in a mouse model of plaque destabilization |
| Q34070358 | The adaptor CRADD/RAIDD controls activation of endothelial cells by proinflammatory stimuli |
| Q38423064 | The inflammatory actions of coagulant and fibrinolytic proteases in disease |
| Q34342288 | The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3‐kinase pathway in maintaining thrombin‐induced platelet aggregation |
| Q37910045 | The roles of thrombin and protease-activated receptors in inflammation |
| Q33566993 | Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway |
| Q38271983 | Thrombin inhibition by dabigatran attenuates atherosclerosis in ApoE deficient mice |
| Q34438768 | Thrombin-dependent NF-{kappa}B activation and monocyte/endothelial adhesion are mediated by the CARMA3·Bcl10·MALT1 signalosome |
| Q27016071 | Unmet needs in the management of acute myocardial infarction: role of novel protease-activated receptor-1 antagonist vorapaxar |
| Q38431157 | Vorapaxar: a review of its use in the long-term secondary prevention of atherothrombotic events |
Search more.